Clinical Trial Update: Association of Plasma Metabolomic Biomarkers with Chronic Ischemic White Matter Injury

View source ↗

Summary

This clinical trial update describes a study examining associations between plasma metabolomic biomarkers and chronic ischemic white matter injury (myelinopathy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemic White Matter Injury
• Myelinopathy

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Myelinopathy | Status: ACTIVE_NOT_RECRUITING